NCT00332514

Brief Summary

The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes. Patients will be interviewed via telephone within 72 hours of being discharged home from the hospital. Patients will be questioned on three main topics. They are:

  1. 1.Medical care
  2. 2.Medications
  3. 3.Follow-up appointments

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2004

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 1, 2006

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

February 23, 2016

Status Verified

March 1, 2006

Enrollment Period

3.8 years

First QC Date

May 31, 2006

Last Update Submit

February 19, 2016

Conditions

Readmission, Hospital

Keywords

pharmacist interventionpost-discharge telephone callblack hole

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period.

Secondary Outcomes (1)

  • The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.

Study Arms (1)

Patients offered follow-up phone call

OTHER

Patients offered follow-up telephone call

Behavioral: telephone call by a pharmacist

Interventions

telephone call by a pharmacistBEHAVIORAL
Patients offered follow-up phone call

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • admission to Internal Medicine Service on the Menino Pavilion, either Firm A or B at Boston Medical Center located in Boston, MA
  • age greater than or equal to 18 years
  • discharge to home from the inpatient General Medical Service
  • English-speaking or lives with English-speaking person
  • access to a working phone

You may not qualify if:

  • admission to any other service at Boston Medical Center located in Boston, MA besides Internal Medicine Firms A or B
  • age less than 18 years
  • discharge to site other than home
  • non-English-speaking or does not live with an English-speaking person
  • no access to a working phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, 02118, United States

Location

Study Officials

  • Gail M Burniske, PharmD, BCPS

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2006

First Posted

June 1, 2006

Study Start

March 1, 2004

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

February 23, 2016

Record last verified: 2006-03

Locations

US(1)